🟢 SAB Biotherapeutics is trading 5% up today with no clear catalyst identified

SAB Biotherapeutics is trading at $2.97, up 5.32%, with no clear company-specific catalyst identified for the October 22 move.

• The company’s investor-relations page lists its latest releases as dated October 14 and October 13, not October 22.
• Major indexes were lower, so the supplied market context does not explain the stock’s gain.
• The FDA Fast Track announcement was October 13, not a new October 22 event.